---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-005140"
form_type: "8-K"
ticker: "OCEA"
cik: "0001869974"
company_name: "Ocean Biomedical, Inc."
filed_at: "2023-02-15T23:59:59+00:00"
generated_at: "2026-06-19T12:13:55.441054+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Ocean Biomedical completes SPAC merger; begins trading on Nasdaq under "OCEA"

## Summary
- Completed business combination with Aesther Healthcare Acquisition Corp.; begins trading on Nasdaq on Feb. 15, 2023 under ticker OCEA.
- Secured up to $60M backstop from Vellar Opportunity Fund and $75M equity line from White Lion Capital.
- Pipeline focused on oncology, pulmonary fibrosis, and infectious disease supported by $123.9M in grants.
- Leadership: Elizabeth Ng CEO, Dr. Chirinjeev Kathuria Executive Chairman, Dr. Jack Elias Scientific Advisory Board Chair.
- Board of directors includes Suren Ajjarapu, Michael Peterson, Martin D. Angle, Dr. Michelle Berry, Jerome Ringo, Gov. William Owens.

## SEC filing metadata
- accession: 0001493152-23-005140
- form_type: 8-K
- ticker: OCEA
- cik: 0001869974
- company_name: Ocean Biomedical, Inc.
- filed_at: 2023-02-15T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1869974/000149315223005140/0001493152-23-005140-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1869974/000149315223005140/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-005140
- JSON: https://secwatch.observer/filing/0001493152-23-005140.json
- Plain text: https://secwatch.observer/filing/0001493152-23-005140.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.